Sharekhan

Anuh Pharma Ltd

Fri 18/07/2025,15:55:40 NSE: ANUHPHR

₹ 94.33 -5.38 (-5.40%)
BUY NOW Buy Anuh Pharma Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Anuh Pharma Ltd

Fri 18/07/2025,16:1:0

Anuh Pharma Ltd

Fri 18/07/2025,15:55:40 | NSE : ANUHPHR

₹ 94.33-5.38 (-5.40%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 99.10

Previous Close

₹ 99.71

Volume

264847

Mkt Cap ( Rs. Cr)

₹945.41

High

₹ 99.10

Low

₹ 93.51

52 Week High

₹ 122.85

52 Week Low

₹ 74.25

Book Value Per Share

₹ 32.53

Dividend Yield

1.58

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Anuh Pharma Ltd

Your Vote -

Buy

85.00%

Hold

10.00%

Sell

5.00%

85.00%

20 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

94.33

198

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

198

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anuh Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anuh Pharma Ltd - Alteration Of Capital and Fund Raising-XBRL

    16 Jul 2025, 11:29AM ANUH PHARMA LIMITED has informed the Exchange regarding Allotment of Securities

  • Anuh Pharma Ltd - Allotment of Securities

    16 Jul 2025, 11:27AM Anuh Pharma Limited has informed the Exchange regarding allotment of securities pursuant to Bonus at its meeting held on 0 ,

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Allotment

    16 Jul 2025, 11:23AM Disclosure regarding allotment of 50112000 equity shares pursuant to Bonus issue.

  • Anuh Pharma Ltd - General Updates

    15 Jul 2025, 2:59PM Anuh Pharma Limited has informed the Exchange about Inauguration of Manufacturing Block INT 1A of the Company

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR) - Inauguration Of Manufacturing Block INT 1A Of The Company.

    15 Jul 2025, 2:50PM This is to inform that the company has inaugurated it's new manufacturing Block INT 1A at E-17/3, E-17/4 & E-18, M.I.D.C., Tarapur, Boisar, Dist Palgh

  • Anuh Pharma Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jul 2025, 5:13PM Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anuh Pharma Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    8 Jul 2025, 5:29PM Enclosed herewith is the Voting Results and Scrutinizer Report for Postal Ballot Notice dated 23rd May, 2025.

  • Anuh Pharma Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2025, 5:08PM Compliance Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2025 r

  • Anuh Pharma Ltd - Record Date

    7 Jul 2025, 5:54PM Anuh Pharma Limited has informed the Exchange that Record date for the purpose of Bonus is 15-Jul-2025.

  • Anuh Pharma Ltd - Corporate Action - Record Date For Issue Of Bonus Equity Shares Of The Company.

    7 Jul 2025, 5:48PM The Company has fixed Tuesday, 15th July, 2025, as the \Record Date\ for the purpose of issuance of Bonus Shares of the Company.

  • Anuh Pharma Ltd - Shareholders meeting

    7 Jul 2025, 3:29PM Anuh Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

  • Anuh Pharma Ltd - Disclosure under SEBI Takeover Regulations

    3 Jul 2025, 11:02PM Anuh Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substanti

  • Anuh Pharma Ltd - Trading Window-XBRL

    26 Jun 2025, 4:43PM ANUH PHARMA LIMITED has informed the Exchange about Closure of Trading Window

  • Anuh Pharma Ltd - Trading Window

    26 Jun 2025, 4:38PM Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Anuh Pharma Ltd - Copy of Newspaper Publication

    7 Jun 2025, 3:49PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication

  • Anuh Pharma Ltd - Investor Presentation

    29 May 2025, 4:55PM Anuh Pharma Limited has informed the Exchange about Investor Presentation

  • Anuh Pharma Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation

    29 May 2025, 4:48PM Investor Presentation for Q4 FY 2024-25

  • Anuh Pharma Ltd - Record Date

    28 May 2025, 4:49PM Anuh Pharma Limited has informed the Exchange that Record date for the purpose of Dividend & Annual General Meeting is 14-Aug-2025.

  • Anuh Pharma Ltd - Corporate Action - Fixes Record Date For Dividend And Annual General Meeting

    28 May 2025, 4:45PM The Record Date for the Dividend and Annual General Meeting is fixed and the same is enclosed herewith.

  • Anuh Pharma Ltd - Copy of Newspaper Publication

    25 May 2025, 12:43PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Audited financial results for the quarter and year ended 31st

  • Anuh Pharma Ltd - Outcome of Board Meeting

    24 May 2025, 1:26AM Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Anuh Pharma Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    23 May 2025, 11:34PM ANUH PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

  • Anuh Pharma Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    23 May 2025, 11:27PM ANUH PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

  • Anuh Pharma Ltd - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    23 May 2025, 11:24PM ANUH PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:22PM Anuh Pharma Limited has informed the Exchange about General Updates for updation of revised polices

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:21PM Anuh Pharma Limited has informed the Exchange about General Updates

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:19PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30 for re-appointment of Cost Auditor

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:17PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30 for re-appointment of Director Retiring by rotation

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:15PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30 for re-appointment of Internal Auditor

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:13PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:11PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30

  • Anuh Pharma Ltd - General Updates

    23 May 2025, 11:09PM Anuh Pharma Limited has informed the Exchange about Disclosure under Regulation 30

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR)

    23 May 2025, 10:15PM Adoption of Revised Policies

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR)

    23 May 2025, 10:13PM Intimation for re-appointment of Joint Managing Directors

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR)

    23 May 2025, 10:10PM Intimation for Re-appointment of Directors retiring by rotation

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR)

    23 May 2025, 10:06PM Re-appointment of Internal Auditor

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR)

    23 May 2025, 10:05PM Re-appointment of Cost Auditor

  • Anuh Pharma Ltd - Announcement Under Regulation 30 (LODR) Appointment Of Secretarial Auditors

    23 May 2025, 10:02PM Appointment of Secretarial Auditor

  • Anuh Pharma Ltd - Corporate Action-Board recommends Bonus Issue

    23 May 2025, 9:56PM Bonus issue of 1 fully paid up Equity shares for every 1 fully paid up existing shares of the company i.e. 1:1.

  • Anuh Pharma Ltd - Corporate Action-Board approves Dividend

    23 May 2025, 9:52PM Final Dividend of Rs. 1.50 (30%) per equity shares of Face Value of Rs. 5 each for the Financial Year ended 31/03/2025

  • Anuh Pharma Ltd - Outcome of Board Meeting-XBRL

    23 May 2025, 9:32PM ANUH PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 23-May-2025 for Dividend/Bonus Shares

  • Anuh Pharma Ltd - Bonus

    23 May 2025, 9:26PM Anuh Pharma Limited has informed the Exchange that the Board of Directors at its meeting held on May 23, 2025, have considered and approved bonus at t

  • Anuh Pharma Ltd - Dividend

    23 May 2025, 9:25PM Anuh Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 23, 2025, recommended Final Dividend of Rs. 1.50 per

  • Anuh Pharma Ltd - Outcome of Board Meeting

    23 May 2025, 9:23PM Anuh Pharma Limited has informed the Exchange regarding the Audited Financial Results for the Board meeting held on May 23, 2025.

  • Anuh Pharma Ltd - Revised Results - Financial Results For March 31, 2025 (Quarter And Year Ended 31/03/2025)

    23 May 2025, 9:10PM Revised Audited Financial Results for quarter and year ended 31st March, 2025

  • Anuh Pharma Ltd - Board Meeting Outcome for Revised Outcome For The Board Meeting Dated 23/05/2025

    23 May 2025, 9:00PM Revised outcome to consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2025, issue of Bonus Equity shares in

  • Anuh Pharma Ltd Q4 net profit down 18.88% at Rs 12.46 cr

    23 May 2025, 8:44PM The company reported standalone net profit of Rs 12.46 crore for the quarter ended March 31, 2025 as compared to Rs 15.36 crore in the same period las

  • Anuh Pharma Ltd - Results - Financials Results For The Year Ended 31/03/2025

    23 May 2025, 8:39PM Financials results

  • Anuh Pharma Ltd - Board Meeting Intimation

    19 May 2025, 2:46PM ANUH PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2025 to consider and approve the Yearly Audited Financial resul

  • Anuh Pharma Ltd - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Financial Year

    19 May 2025, 2:37PM Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and appr

  • Anuh Pharma Ltd - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    28 Apr 2025, 4:50PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Anuh Pharma gets nod from WHO

    29 Sep 2020 , 10:28AM Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anuh Pharma Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 336.5229 293.2313 241.2214 216.8838 204.2412
Liabilities 336.5229 293.2313 241.2214 216.8838 204.2412
Equity 25.056 25.056 25.056 25.056 25.056
Gross Profit 60.9087 75.1491 51.2745 46.8455 44.5835
Net Profit 47.3519 60.0575 36.1796 30.5613 28.4363
Cash From Operating Activities 37.1248 12.9251 53.9016 28.8637 -18.7347
NPM(%) 7.15 9.28 6.85 6.27 6.58
Revenue 661.5149 647.0043 527.486 486.6462 431.9601
Expenses 600.6062 571.8552 476.2115 439.8007 387.3766
ROE(%) 14.52 18.42 11.09 9.37 8.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
14 Aug 2025 1.5 30 1.59 207.39

Peers

Other companies within the same industry or sector that are comparable to Anuh Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 933.30 0.89 30.97 53.88 301.39 0.54
Lotus Eye Hospital and Institute Ltd 75.41 1.51 215.46 196.32 3.55 0.00
Vaishali Pharma Ltd 12.77 -1.69 212.83 101.19 3.13 0.00
Astec Lifesciences Ltd 901.45 -0.84 0.00 185.13 -601.21 0.00

Company Info

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.

Read More

Parent Organisation

Anuh Pharma Ltd.

Founded

19/02/1960

Managing Director

Mr.Vivek B Shah

NSE Symbol

ANUHPHREQ

FAQ

The current price of Anuh Pharma Ltd is ₹ 94.33.

The 52-week high for Anuh Pharma Ltd is ₹ 99.10 and the 52-week low is ₹ 93.51.

The market capitalization of Anuh Pharma Ltd is currently ₹ 945.41. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anuh Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anuh Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anuh Pharma Ltd shares.

The CEO of Anuh Pharma Ltd is Mr.Vivek B Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT